Navigation Links
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions
Date:6/29/2010

nt adverse events or observations of hypoglycemia. The most common adverse event was mild injection site reactions.  

"We have demonstrated that our PTP-1B inhibitor has a very attractive profile in two Phase 2 studies in patients with type 2 diabetes.  A novel insulin sensitizer that reduces high blood glucose without resulting in hypoglycemia, reduces LDL-cholesterol and decreases weight would be a significant advance in the treatment of type 2 diabetes," said Sanjay Bhanot, M.D., Ph.D., Vice President of Metabolics and Translational Medicine at Isis.  "In this study, we observed reductions in multiple measures of glucose control that were consistent with our expectations for a 13-week study. We believe that with longer-term treatment we should also see reductions in longer-term measures of glucose control.  We are excited to continue to move this program forward and to evaluate PTP-1B inhibition in longer studies in combination with other commonly prescribed type 2 diabetes drugs."

In the oral presentation titled "First Proof of Pharmacology of a Novel Glucagon Receptor Antisense Drug in Humans," Dr. Bhanot presented the results of a Phase 1 study on ISIS-GCGRRx. The study, which included a glucagon challenge that doubled both plasma glucagon and glucose levels, produced the following results:

  • Statistically significant improvement in blood glucose levels and reduced liver glucose production following the glucagon challenge at a dose of 400 mg/week
  • No clinically significant adverse events or observations of hypoglycemia. The most common adverse event was mild injection site reactions.  

"In our Phase 1 study of ISIS-GCGRRx we achieved reductions in blood glucose following a glucagon challenge.  This re
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders
2. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
3. DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2010 Corporate Highlights and Financial Results Conference Call
4. LightLab Highlights OCT Market Leadership at the Society for Cardiovascular Angiography and Interventions
5. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
6. Bionovo Announces 2009 Highlights and Year-End Financial Results
7. Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010
8. New Publication Highlights 2-Year Durability and Effectiveness of Macroplastique(R)
9. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
10. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
11. Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 The Bio-Process Systems Alliance ... Annual International Single-Use Summit (ISUS 2015) will be ... , with a primary focus on the promises ... From technical topics to business and regulatory presentations, ... the emergence of the single-use industry as the "go-to" ...
(Date:5/27/2015)...  Foundation Health Care  (FDNH), which owns and operates ... today it will present at the LD Micro Invitational ... Sunset Boulevard Hotel, Los Angeles, CA. ... nd at 3:00pm and will also be available ... contact LD Micro. For more information about the conference, ...
(Date:5/27/2015)... REDWOOD CITY, Calif. , May 27, 2015  Genomic ... Brad Cole , Chief Operating Officer and Chief Financial Officer, ... New York City on Monday, June ... access the live and subsequently archived webcast of the presentation, ... site at http://investor.genomichealth.com .  Please connect to the web ...
Breaking Medicine Technology:BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 2BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3
... Feb. 28, 2011 The staffs of Chiltern International ... Spectratox Limited, celebrate the 25 year mark of their ... Early Phase and Spectratox have worked together using a ... study method for the assessment of drug phototoxicity. The ...
... for Ethical Imaging (CEI), a grassroots coalition with the ... supporting House Bill 1809, sponsored by Representative Senfronia Thompson. ... in healthcare costs in the state while ensuring patient ... medical professionals, members of the business community interested in ...
Cached Medicine Technology:Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 2Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 3Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 2Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 3
(Date:5/27/2015)... (PRWEB) May 27, 2015 Dr. Omar ... based in Stamford, CT has been selected as part ... first physicians nationwide (and the only physician in Connecticut) ... which allows for the removal of submental fat (double ... no recovery time, no surgery and minimal risks. Dr. ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ... for enterprise organizations, announced today that SanMar Corporation ... its time, attendance and point tracking processes for ... United States. , Family-owned since 1971, Seattle-based ... retail, private label, and mill brands. SanMar supplies ...
(Date:5/27/2015)... In support of a new ... the Journal of American Geriatrics Society about the link ... Bedford Commons OB-GYN P.A . is reiterating the nutritional ... , To examine the relationship between diet soda ... Longitudinal Study of Aging (SALSA) tracked the soda consumption ...
(Date:5/27/2015)... The Case Management Society of ... provide CMSA's Career and Knowledge Pathways educational program ... strengthen the case/care management workforce by offering aptitude ... mutually beneficial agreement provides Medix, a workforce solutions ... in the healthcare, scientific and IT industries, access ...
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 ... the first healthcare provider along the Gulf Coast ... management (CCM). In partnership with MD Revolution, a ... a new program that enables healthcare providers to ... reimbursements. This new, user-friendly program is designed to ...
Breaking Medicine News(10 mins):Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3
... Dec. 16 Pennsylvania, along with 31 other states ... settlement with Airborne Health, Inc., and its owners, over ... containing their Airborne Effervescent Health Formula. Pennsylvania will receive ... Attorney General Tom Corbett said that Airborne Health, ...
... Dec. 16 A study comparing breastfed and formula ... of breastfeeding are greater than the potential risks associated with ... present in breastmilk, according to a report published in the ... , a peer-reviewed journal published by Mary Ann Liebert, ...
... deadly,bacteria in lungs , , TUESDAY, Dec. 16 (HealthDay News) ... in the lungs of cystic fibrosis patients are signaling ... The pigments may enable infectious Pseudomonas aeruginosa ... Massachusetts Institute of Technology (MIT) study. , The ...
... Structural interventions and public safety messages may be the ... the overall safety of New York City subway systems, ... Mailman School of Public Health. Subway safety is important ... mode of transportation, it has the highest fatality rate ...
... Healthcare Management Systems,Inc.(R) (HMS) announced today that it ... system of integrated clinical and financial software. For the,20-bed ... HMS,system reinforces their commitment to providing quality, patient-centered care,for ... Kimball Health Services has some healthcare technology in place ...
... (TSX, FSE: HBP) reports that at its Annual General Meeting held today, shareholders overwhelmingly ... General Meeting Results , , All seven Board ... , , , ... and Chief Executive Officer, Kenneth A. Cawkell ...
Cached Medicine News:Health News:Pennsylvania Attorney General Corbett Announces a Multi-State, $7 Million Settlement With Airborne Health, Inc., Over Charges of Deceptive Advertising 2Health News:Benefits of Breastfeeding Outweigh Risk of Infant Exposure to Environmental Chemicals in Breastmilk 2Health News:Benefits of Breastfeeding Outweigh Risk of Infant Exposure to Environmental Chemicals in Breastmilk 3Health News:Scientists Spot Key to Cystic Fibrosis Infections 2Health News:'Don't drink and ride': Improving subway safety 2Health News:Kimball Health Services Selects HMS to Provide Information Technology Infrastructure 2Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 2Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 3Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 4Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 5
One channel transcranial Doppler...
Locates flow easily, and identifies flow depth and direction for multiple vessels simultaneously....
... an advanced Doppler system that allows non-invasive ... body. This method of measurement is particularly ... blood to the brain. , ,TCD is ... problems such as vasospasm and intracranial stenosis. ...
Swiss Watchmaker Forceps, 4" extra-long precision ground points....
Medicine Products: